IBDEI06V ; ; 01-MAY-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 01, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16726,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16726,1,2,0)
 ;;=2^99386
 ;;^UTILITY(U,$J,358.3,16726,1,3,0)
 ;;=3^Preventive Med,New Pt,40-64
 ;;^UTILITY(U,$J,358.3,16727,0)
 ;;=99387^^64^752^3^^^^1
 ;;^UTILITY(U,$J,358.3,16727,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16727,1,2,0)
 ;;=2^99387
 ;;^UTILITY(U,$J,358.3,16727,1,3,0)
 ;;=3^Preventive Med,New Pt > 64 
 ;;^UTILITY(U,$J,358.3,16728,0)
 ;;=99452^^64^753^1^^^^1
 ;;^UTILITY(U,$J,358.3,16728,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,16728,1,2,0)
 ;;=2^99452
 ;;^UTILITY(U,$J,358.3,16728,1,3,0)
 ;;=3^E-Consult Results/Discussion with Patient
 ;;^UTILITY(U,$J,358.3,16729,0)
 ;;=B18.2^^65^754^38
 ;;^UTILITY(U,$J,358.3,16729,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16729,1,3,0)
 ;;=3^Hepatitis C,Chr
 ;;^UTILITY(U,$J,358.3,16729,1,4,0)
 ;;=4^B18.2
 ;;^UTILITY(U,$J,358.3,16729,2)
 ;;=^5000548
 ;;^UTILITY(U,$J,358.3,16730,0)
 ;;=E11.9^^65^754^23
 ;;^UTILITY(U,$J,358.3,16730,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16730,1,3,0)
 ;;=3^Diabetes Type 2
 ;;^UTILITY(U,$J,358.3,16730,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,16730,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,16731,0)
 ;;=E11.40^^65^754^21
 ;;^UTILITY(U,$J,358.3,16731,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16731,1,3,0)
 ;;=3^DM Type 2 w/ Neuropathy
 ;;^UTILITY(U,$J,358.3,16731,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,16731,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,16732,0)
 ;;=E78.2^^65^754^39
 ;;^UTILITY(U,$J,358.3,16732,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16732,1,3,0)
 ;;=3^Hyperlipidemia,Mixed
 ;;^UTILITY(U,$J,358.3,16732,1,4,0)
 ;;=4^E78.2
 ;;^UTILITY(U,$J,358.3,16732,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,16733,0)
 ;;=E78.5^^65^754^40
 ;;^UTILITY(U,$J,358.3,16733,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16733,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,16733,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,16733,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,16734,0)
 ;;=E66.3^^65^754^57
 ;;^UTILITY(U,$J,358.3,16734,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16734,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,16734,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,16734,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,16735,0)
 ;;=F17.200^^65^754^50
 ;;^UTILITY(U,$J,358.3,16735,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16735,1,3,0)
 ;;=3^Nicotine Dependence,Unspec
 ;;^UTILITY(U,$J,358.3,16735,1,4,0)
 ;;=4^F17.200
 ;;^UTILITY(U,$J,358.3,16735,2)
 ;;=^5003360
 ;;^UTILITY(U,$J,358.3,16736,0)
 ;;=G43.909^^65^754^48
 ;;^UTILITY(U,$J,358.3,16736,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16736,1,3,0)
 ;;=3^Migraine,Unspec
 ;;^UTILITY(U,$J,358.3,16736,1,4,0)
 ;;=4^G43.909
 ;;^UTILITY(U,$J,358.3,16736,2)
 ;;=^5003909
 ;;^UTILITY(U,$J,358.3,16737,0)
 ;;=H91.93^^65^754^34
 ;;^UTILITY(U,$J,358.3,16737,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16737,1,3,0)
 ;;=3^Hearing Loss,Bilateral
 ;;^UTILITY(U,$J,358.3,16737,1,4,0)
 ;;=4^H91.93
 ;;^UTILITY(U,$J,358.3,16737,2)
 ;;=^5006944
 ;;^UTILITY(U,$J,358.3,16738,0)
 ;;=I10.^^65^754^41
 ;;^UTILITY(U,$J,358.3,16738,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16738,1,3,0)
 ;;=3^Hypertension
 ;;^UTILITY(U,$J,358.3,16738,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,16738,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,16739,0)
 ;;=I50.9^^65^754^17
 ;;^UTILITY(U,$J,358.3,16739,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16739,1,3,0)
 ;;=3^Congestive Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,16739,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,16739,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,16740,0)
 ;;=I67.89^^65^754^16
 ;;^UTILITY(U,$J,358.3,16740,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16740,1,3,0)
 ;;=3^Cerebrovascular Disease,Oth
 ;;^UTILITY(U,$J,358.3,16740,1,4,0)
 ;;=4^I67.89
 ;;^UTILITY(U,$J,358.3,16740,2)
 ;;=^5007388
 ;;^UTILITY(U,$J,358.3,16741,0)
 ;;=J45.909^^65^754^4
 ;;^UTILITY(U,$J,358.3,16741,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16741,1,3,0)
 ;;=3^Asthma,Unspec,Uncomplicated
 ;;^UTILITY(U,$J,358.3,16741,1,4,0)
 ;;=4^J45.909
 ;;^UTILITY(U,$J,358.3,16741,2)
 ;;=^5008256
 ;;^UTILITY(U,$J,358.3,16742,0)
 ;;=J44.9^^65^754^14
 ;;^UTILITY(U,$J,358.3,16742,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16742,1,3,0)
 ;;=3^COPD,Unspec
 ;;^UTILITY(U,$J,358.3,16742,1,4,0)
 ;;=4^J44.9
 ;;^UTILITY(U,$J,358.3,16742,2)
 ;;=^5008241
 ;;^UTILITY(U,$J,358.3,16743,0)
 ;;=K21.9^^65^754^29
 ;;^UTILITY(U,$J,358.3,16743,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16743,1,3,0)
 ;;=3^GERD w/o Esophagitis
 ;;^UTILITY(U,$J,358.3,16743,1,4,0)
 ;;=4^K21.9
 ;;^UTILITY(U,$J,358.3,16743,2)
 ;;=^5008505
 ;;^UTILITY(U,$J,358.3,16744,0)
 ;;=N40.1^^65^754^27
 ;;^UTILITY(U,$J,358.3,16744,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16744,1,3,0)
 ;;=3^Enlarged Prostate w/ LUTS
 ;;^UTILITY(U,$J,358.3,16744,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,16744,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,16745,0)
 ;;=L03.818^^65^754^15
 ;;^UTILITY(U,$J,358.3,16745,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16745,1,3,0)
 ;;=3^Cellulitis,Oth Sites
 ;;^UTILITY(U,$J,358.3,16745,1,4,0)
 ;;=4^L03.818
 ;;^UTILITY(U,$J,358.3,16745,2)
 ;;=^5009064
 ;;^UTILITY(U,$J,358.3,16746,0)
 ;;=G47.33^^65^754^75
 ;;^UTILITY(U,$J,358.3,16746,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16746,1,3,0)
 ;;=3^Sleep Apnea,Obstructive
 ;;^UTILITY(U,$J,358.3,16746,1,4,0)
 ;;=4^G47.33
 ;;^UTILITY(U,$J,358.3,16746,2)
 ;;=^332763
 ;;^UTILITY(U,$J,358.3,16747,0)
 ;;=R73.01^^65^754^44
 ;;^UTILITY(U,$J,358.3,16747,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16747,1,3,0)
 ;;=3^Impaired Fasting Glucose
 ;;^UTILITY(U,$J,358.3,16747,1,4,0)
 ;;=4^R73.01
 ;;^UTILITY(U,$J,358.3,16747,2)
 ;;=^5019561
 ;;^UTILITY(U,$J,358.3,16748,0)
 ;;=R74.8^^65^754^1
 ;;^UTILITY(U,$J,358.3,16748,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16748,1,3,0)
 ;;=3^Abnormal Levels of Serum Enzymes
 ;;^UTILITY(U,$J,358.3,16748,1,4,0)
 ;;=4^R74.8
 ;;^UTILITY(U,$J,358.3,16748,2)
 ;;=^5019566
 ;;^UTILITY(U,$J,358.3,16749,0)
 ;;=R03.0^^65^754^25
 ;;^UTILITY(U,$J,358.3,16749,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16749,1,3,0)
 ;;=3^Elevated BP Reading w/o Diagnosis of HTN
 ;;^UTILITY(U,$J,358.3,16749,1,4,0)
 ;;=4^R03.0
 ;;^UTILITY(U,$J,358.3,16749,2)
 ;;=^5019171
 ;;^UTILITY(U,$J,358.3,16750,0)
 ;;=Z91.19^^65^754^51
 ;;^UTILITY(U,$J,358.3,16750,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16750,1,3,0)
 ;;=3^Noncompliance w/ Medical Treatment/Regimen
 ;;^UTILITY(U,$J,358.3,16750,1,4,0)
 ;;=4^Z91.19
 ;;^UTILITY(U,$J,358.3,16750,2)
 ;;=^5063618
 ;;^UTILITY(U,$J,358.3,16751,0)
 ;;=E66.01^^65^754^52
 ;;^UTILITY(U,$J,358.3,16751,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16751,1,3,0)
 ;;=3^Obesity,Morbid
 ;;^UTILITY(U,$J,358.3,16751,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,16751,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,16752,0)
 ;;=F43.11^^65^754^59
 ;;^UTILITY(U,$J,358.3,16752,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16752,1,3,0)
 ;;=3^PTSD,Acute
 ;;^UTILITY(U,$J,358.3,16752,1,4,0)
 ;;=4^F43.11
 ;;^UTILITY(U,$J,358.3,16752,2)
 ;;=^5003571
 ;;^UTILITY(U,$J,358.3,16753,0)
 ;;=F43.12^^65^754^60
 ;;^UTILITY(U,$J,358.3,16753,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16753,1,3,0)
 ;;=3^PTSD,Chronic
 ;;^UTILITY(U,$J,358.3,16753,1,4,0)
 ;;=4^F43.12
 ;;^UTILITY(U,$J,358.3,16753,2)
 ;;=^5003572
 ;;^UTILITY(U,$J,358.3,16754,0)
 ;;=I25.119^^65^754^5
 ;;^UTILITY(U,$J,358.3,16754,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16754,1,3,0)
 ;;=3^Athscl Hrt Dis of Native Cor Art w/ Ang Pctrs,Unspec
 ;;^UTILITY(U,$J,358.3,16754,1,4,0)
 ;;=4^I25.119
 ;;^UTILITY(U,$J,358.3,16754,2)
 ;;=^5007111
 ;;^UTILITY(U,$J,358.3,16755,0)
 ;;=I25.10^^65^754^6
 ;;^UTILITY(U,$J,358.3,16755,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16755,1,3,0)
 ;;=3^Athscl Hrt Dis of Native Cor Art w/o Ang Pctrs
 ;;^UTILITY(U,$J,358.3,16755,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,16755,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,16756,0)
 ;;=F17.219^^65^754^49
 ;;^UTILITY(U,$J,358.3,16756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16756,1,3,0)
 ;;=3^Nicotine Dependence,Cigarettes
 ;;^UTILITY(U,$J,358.3,16756,1,4,0)
 ;;=4^F17.219
 ;;^UTILITY(U,$J,358.3,16756,2)
 ;;=^5003369
 ;;^UTILITY(U,$J,358.3,16757,0)
 ;;=Z51.5^^65^754^62
 ;;^UTILITY(U,$J,358.3,16757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16757,1,3,0)
 ;;=3^Palliative Care Encounter
 ;;^UTILITY(U,$J,358.3,16757,1,4,0)
 ;;=4^Z51.5
 ;;^UTILITY(U,$J,358.3,16757,2)
 ;;=^5063063
 ;;^UTILITY(U,$J,358.3,16758,0)
 ;;=Z23.^^65^754^26
 ;;^UTILITY(U,$J,358.3,16758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16758,1,3,0)
 ;;=3^Encounter for Immunization(s)
 ;;^UTILITY(U,$J,358.3,16758,1,4,0)
 ;;=4^Z23.
 ;;^UTILITY(U,$J,358.3,16758,2)
 ;;=^5062795
 ;;^UTILITY(U,$J,358.3,16759,0)
 ;;=E11.65^^65^754^18
 ;;^UTILITY(U,$J,358.3,16759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16759,1,3,0)
 ;;=3^DM Type 2 Uncontrolled w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,16759,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,16759,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,16760,0)
 ;;=E11.649^^65^754^19
 ;;^UTILITY(U,$J,358.3,16760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16760,1,3,0)
 ;;=3^DM Type 2 Uncontrolled w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,16760,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,16760,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,16761,0)
 ;;=I16.0^^65^754^42
 ;;^UTILITY(U,$J,358.3,16761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16761,1,3,0)
 ;;=3^Hypertensive Urgency
 ;;^UTILITY(U,$J,358.3,16761,1,4,0)
 ;;=4^I16.0
 ;;^UTILITY(U,$J,358.3,16761,2)
 ;;=^8133013
 ;;^UTILITY(U,$J,358.3,16762,0)
 ;;=H54.8^^65^754^45
 ;;^UTILITY(U,$J,358.3,16762,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16762,1,3,0)
 ;;=3^Legal Blindness,USA Definition
 ;;^UTILITY(U,$J,358.3,16762,1,4,0)
 ;;=4^H54.8
 ;;^UTILITY(U,$J,358.3,16762,2)
 ;;=^5006369
 ;;^UTILITY(U,$J,358.3,16763,0)
 ;;=F10.10^^65^754^2
 ;;^UTILITY(U,$J,358.3,16763,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16763,1,3,0)
 ;;=3^Alcohol Abuse,Uncomplicated
 ;;^UTILITY(U,$J,358.3,16763,1,4,0)
 ;;=4^F10.10
 ;;^UTILITY(U,$J,358.3,16763,2)
 ;;=^5003068
 ;;^UTILITY(U,$J,358.3,16764,0)
 ;;=J30.9^^65^754^3
 ;;^UTILITY(U,$J,358.3,16764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16764,1,3,0)
 ;;=3^Allergic Rhinitis,Unspec
 ;;^UTILITY(U,$J,358.3,16764,1,4,0)
 ;;=4^J30.9
 ;;^UTILITY(U,$J,358.3,16764,2)
 ;;=^5008205
 ;;^UTILITY(U,$J,358.3,16765,0)
 ;;=I48.0^^65^754^7
 ;;^UTILITY(U,$J,358.3,16765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16765,1,3,0)
 ;;=3^Atrial Fibrillation Paroxysmal (PAF)
 ;;^UTILITY(U,$J,358.3,16765,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,16765,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,16766,0)
 ;;=N18.1^^65^754^9
 ;;^UTILITY(U,$J,358.3,16766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16766,1,3,0)
 ;;=3^CKD,Stage 1
 ;;^UTILITY(U,$J,358.3,16766,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,16766,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,16767,0)
 ;;=N18.2^^65^754^10
 ;;^UTILITY(U,$J,358.3,16767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16767,1,3,0)
 ;;=3^CKD,Stage 2
 ;;^UTILITY(U,$J,358.3,16767,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,16767,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,16768,0)
 ;;=N18.3^^65^754^11
 ;;^UTILITY(U,$J,358.3,16768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16768,1,3,0)
 ;;=3^CKD,Stage 3
 ;;^UTILITY(U,$J,358.3,16768,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,16768,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,16769,0)
 ;;=N18.4^^65^754^12
 ;;^UTILITY(U,$J,358.3,16769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16769,1,3,0)
 ;;=3^CKD,Stage 4
 ;;^UTILITY(U,$J,358.3,16769,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,16769,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,16770,0)
 ;;=N18.5^^65^754^13
 ;;^UTILITY(U,$J,358.3,16770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16770,1,3,0)
 ;;=3^CKD,Stage 5
 ;;^UTILITY(U,$J,358.3,16770,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,16770,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,16771,0)
 ;;=N18.6^^65^754^24
 ;;^UTILITY(U,$J,358.3,16771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16771,1,3,0)
 ;;=3^ESRD
 ;;^UTILITY(U,$J,358.3,16771,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,16771,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,16772,0)
 ;;=E11.22^^65^754^20
 ;;^UTILITY(U,$J,358.3,16772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16772,1,3,0)
 ;;=3^DM Type 2 w/ CKD
 ;;^UTILITY(U,$J,358.3,16772,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,16772,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,16773,0)
 ;;=E11.319^^65^754^22
 ;;^UTILITY(U,$J,358.3,16773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16773,1,3,0)
 ;;=3^DM Type 2 w/ Retinopathy Unspec w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,16773,1,4,0)
 ;;=4^E11.319
 ;;^UTILITY(U,$J,358.3,16773,2)
 ;;=^5002633
 ;;^UTILITY(U,$J,358.3,16774,0)
 ;;=G40.909^^65^754^74
 ;;^UTILITY(U,$J,358.3,16774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16774,1,3,0)
 ;;=3^Seizure Disorder NOS
 ;;^UTILITY(U,$J,358.3,16774,1,4,0)
 ;;=4^G40.909
 ;;^UTILITY(U,$J,358.3,16774,2)
 ;;=^5003865
 ;;^UTILITY(U,$J,358.3,16775,0)
 ;;=N52.9^^65^754^28
 ;;^UTILITY(U,$J,358.3,16775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16775,1,3,0)
 ;;=3^Erectile Dysfuntion,Unspec
 ;;^UTILITY(U,$J,358.3,16775,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,16775,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,16776,0)
 ;;=I50.22^^65^754^37
 ;;^UTILITY(U,$J,358.3,16776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16776,1,3,0)
 ;;=3^Heart Failure,Systolic,Chronic
 ;;^UTILITY(U,$J,358.3,16776,1,4,0)
 ;;=4^I50.22
 ;;^UTILITY(U,$J,358.3,16776,2)
 ;;=^5007241
 ;;^UTILITY(U,$J,358.3,16777,0)
 ;;=I50.32^^65^754^35
 ;;^UTILITY(U,$J,358.3,16777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16777,1,3,0)
 ;;=3^Heart Failure,Diastolic,Chronic
 ;;^UTILITY(U,$J,358.3,16777,1,4,0)
 ;;=4^I50.32
 ;;^UTILITY(U,$J,358.3,16777,2)
 ;;=^5007245
 ;;^UTILITY(U,$J,358.3,16778,0)
 ;;=I50.42^^65^754^36
 ;;^UTILITY(U,$J,358.3,16778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16778,1,3,0)
 ;;=3^Heart Failure,Systolic & Diastolic,Chronic
 ;;^UTILITY(U,$J,358.3,16778,1,4,0)
 ;;=4^I50.42
 ;;^UTILITY(U,$J,358.3,16778,2)
 ;;=^5007249
 ;;^UTILITY(U,$J,358.3,16779,0)
 ;;=I13.0^^65^754^30
 ;;^UTILITY(U,$J,358.3,16779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16779,1,3,0)
 ;;=3^HTN Hrt & CKD w/ Hrt Fail w/ Stage 1-4 Chr Kdny
 ;;^UTILITY(U,$J,358.3,16779,1,4,0)
 ;;=4^I13.0
 ;;^UTILITY(U,$J,358.3,16779,2)
 ;;=^5007067
 ;;^UTILITY(U,$J,358.3,16780,0)
 ;;=I13.2^^65^754^31
 ;;^UTILITY(U,$J,358.3,16780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16780,1,3,0)
 ;;=3^HTN Hrt & CKD w/ Hrt Fail w/ Stage 5 Chr Kdny
 ;;^UTILITY(U,$J,358.3,16780,1,4,0)
 ;;=4^I13.2
 ;;^UTILITY(U,$J,358.3,16780,2)
 ;;=^5007070
 ;;^UTILITY(U,$J,358.3,16781,0)
 ;;=I13.10^^65^754^32
 ;;^UTILITY(U,$J,358.3,16781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16781,1,3,0)
 ;;=3^HTN Hrt & CKD w/o Hrt Fail w/ Stage 1-4 Chr Kdny
 ;;^UTILITY(U,$J,358.3,16781,1,4,0)
 ;;=4^I13.10
 ;;^UTILITY(U,$J,358.3,16781,2)
 ;;=^5007068
 ;;^UTILITY(U,$J,358.3,16782,0)
 ;;=I13.11^^65^754^33
 ;;^UTILITY(U,$J,358.3,16782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16782,1,3,0)
 ;;=3^HTN Hrt & CKD w/o Hrt Fail w/ Stage 5 Chr Kdny
 ;;^UTILITY(U,$J,358.3,16782,1,4,0)
 ;;=4^I13.11
 ;;^UTILITY(U,$J,358.3,16782,2)
 ;;=^5007069
 ;;^UTILITY(U,$J,358.3,16783,0)
 ;;=E03.9^^65^754^43
 ;;^UTILITY(U,$J,358.3,16783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16783,1,3,0)
 ;;=3^Hypothyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,16783,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,16783,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,16784,0)
 ;;=M54.5^^65^754^46
 ;;^UTILITY(U,$J,358.3,16784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16784,1,3,0)
 ;;=3^Low Back Pain
 ;;^UTILITY(U,$J,358.3,16784,1,4,0)
 ;;=4^M54.5
 ;;^UTILITY(U,$J,358.3,16784,2)
 ;;=^5012311
 ;;^UTILITY(U,$J,358.3,16785,0)
 ;;=C61.^^65^754^47
 ;;^UTILITY(U,$J,358.3,16785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16785,1,3,0)
 ;;=3^Malig Neopl Prostate
 ;;^UTILITY(U,$J,358.3,16785,1,4,0)
 ;;=4^C61.
 ;;^UTILITY(U,$J,358.3,16785,2)
 ;;=^267239
 ;;^UTILITY(U,$J,358.3,16786,0)
 ;;=F11.20^^65^754^53
 ;;^UTILITY(U,$J,358.3,16786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16786,1,3,0)
 ;;=3^Opioid Dependence,Uncomplicated
 ;;^UTILITY(U,$J,358.3,16786,1,4,0)
 ;;=4^F11.20
 ;;^UTILITY(U,$J,358.3,16786,2)
 ;;=^5003127
 ;;^UTILITY(U,$J,358.3,16787,0)
 ;;=M19.90^^65^754^54
 ;;^UTILITY(U,$J,358.3,16787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16787,1,3,0)
 ;;=3^Osteoarthritis,Unspec
 ;;^UTILITY(U,$J,358.3,16787,1,4,0)
 ;;=4^M19.90
 ;;^UTILITY(U,$J,358.3,16787,2)
 ;;=^5010853
 ;;^UTILITY(U,$J,358.3,16788,0)
 ;;=M85.80^^65^754^55
 ;;^UTILITY(U,$J,358.3,16788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16788,1,3,0)
 ;;=3^Osteopenia,Unspec Site
 ;;^UTILITY(U,$J,358.3,16788,1,4,0)
 ;;=4^M85.80
 ;;^UTILITY(U,$J,358.3,16788,2)
 ;;=^5014473
 ;;^UTILITY(U,$J,358.3,16789,0)
 ;;=M81.0^^65^754^56
 ;;^UTILITY(U,$J,358.3,16789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16789,1,3,0)
 ;;=3^Osteoporosis,Age-Related w/o Fx
 ;;^UTILITY(U,$J,358.3,16789,1,4,0)
 ;;=4^M81.0
 ;;^UTILITY(U,$J,358.3,16789,2)
 ;;=^5013555
 ;;^UTILITY(U,$J,358.3,16790,0)
 ;;=I73.9^^65^754^63
 ;;^UTILITY(U,$J,358.3,16790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16790,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,16790,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,16790,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,16791,0)
 ;;=R21.^^65^754^66
 ;;^UTILITY(U,$J,358.3,16791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16791,1,3,0)
 ;;=3^Rash
 ;;^UTILITY(U,$J,358.3,16791,1,4,0)
 ;;=4^R21.
 ;;^UTILITY(U,$J,358.3,16791,2)
 ;;=^5019283
 ;;^UTILITY(U,$J,358.3,16792,0)
 ;;=Z12.11^^65^754^71
 ;;^UTILITY(U,$J,358.3,16792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16792,1,3,0)
 ;;=3^Screening,Colon CA
 ;;^UTILITY(U,$J,358.3,16792,1,4,0)
 ;;=4^Z12.11
 ;;^UTILITY(U,$J,358.3,16792,2)
 ;;=^5062681
 ;;^UTILITY(U,$J,358.3,16793,0)
 ;;=Z12.39^^65^754^69
 ;;^UTILITY(U,$J,358.3,16793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16793,1,3,0)
 ;;=3^Screening,Breast CA
 ;;^UTILITY(U,$J,358.3,16793,1,4,0)
 ;;=4^Z12.39
 ;;^UTILITY(U,$J,358.3,16793,2)
 ;;=^5062686
 ;;^UTILITY(U,$J,358.3,16794,0)
 ;;=Z12.4^^65^754^70
 ;;^UTILITY(U,$J,358.3,16794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16794,1,3,0)
 ;;=3^Screening,Cervical CA
 ;;^UTILITY(U,$J,358.3,16794,1,4,0)
 ;;=4^Z12.4
 ;;^UTILITY(U,$J,358.3,16794,2)
 ;;=^5062687
 ;;^UTILITY(U,$J,358.3,16795,0)
 ;;=Z13.6^^65^754^68
 ;;^UTILITY(U,$J,358.3,16795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16795,1,3,0)
 ;;=3^Screening,AAA
 ;;^UTILITY(U,$J,358.3,16795,1,4,0)
 ;;=4^Z13.6
 ;;^UTILITY(U,$J,358.3,16795,2)
 ;;=^5062707
 ;;^UTILITY(U,$J,358.3,16796,0)
 ;;=Z11.3^^65^754^73
 ;;^UTILITY(U,$J,358.3,16796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16796,1,3,0)
 ;;=3^Screening,STI
 ;;^UTILITY(U,$J,358.3,16796,1,4,0)
 ;;=4^Z11.3
 ;;^UTILITY(U,$J,358.3,16796,2)
 ;;=^5062672
 ;;^UTILITY(U,$J,358.3,16797,0)
 ;;=Z13.1^^65^754^72
